Litecoin is entering the corporate treasury world as Nasdaq-listed biotech firm MEI Pharma raised $100M to fund a Litecoin treasury strategy. Charlie Lee, creator of the altcoin, joins GSR Chief Strategy Officer Joshua Riezman to discuss the recent move and what's next on Litecoin's roadmap. - This content should not be construed or relied upon as investment advice. It is for entertainment and general information purposes. - Midnight is introducing a novel approach to token distribution. The Midnight Glacier Drop is a multi-phase distribution of the NIGHT token, aimed at empowering a broad, diverse community to build the future of the Midnight network. Holders of ADA, BTC, ETH, SOL, XRP, BNB, AVAX and BAT are eligible to participate in the first phase. Help usher in the next generation of blockchain with rational privacy and cooperative tokenomics on the Midnight network. To learn more, visit https://www.midnight.gd/ and prepare for the Midnight Glacier Drop. - Timestamps: 01:16 Litecoin's Institutional Adoption and Benefits 02:58 Litecoin vs. Bitcoin and Stablecoins 05:19 Institutional Interest in Litecoin 07:25 Future of Crypto Treasury Companies 09:16 Impact of Litecoin on MEI Pharma 11:50 Litecoin's Roadmap and Future Developments - #cryptocurrency #digitalfinance #finance #bitcoin #crypto Subscribe to CoinDesk on YouTube: https://www.youtube.com/user/CoinDesk?sub_confirmation=1 CoinDesk is the leading digital media, events and information services company for the crypto asset and blockchain technology community. Twitter: https://www.twitter.com/coindesk LinkedIn: https://www.din.com/company/coindesk Instagram: https://www.instagram.com/coindesk Facebook: https://www.facebook.com/CoinDesk Newsletters: https://www.coindesk.com/newsletters CoinDesk Podcast Network: https://open.spotify.com/show/2jyIhkvAQhed8AWDZiPpSP Markets Daily Crypto Roundup: https://open.spotify.com/show/7sDXM8BlxsUqzL2IqmLqwE
Why This Nasdaq Company Is Diversifying Into Litecoin
Litecoin is entering the corporate treasury world as Nasdaq-listed biotech firm MEI Pharma raised $100M to fund a Litecoin treasury strategy. Charlie Lee, creator of the altcoin, joins GSR Chief Strategy Officer Joshua Riezman to discuss the recent move and what's next on Litecoin's roadmap. - This content should not be construed or relied upon as investment advice. It is for entertainment and general information purposes. - Midnight is introducing a novel approach to token distribution. The Midnight Glacier Drop is a multi-phase distribution of the NIGHT token, aimed at empowering a broad, diverse community to build the future of the Midnight network. Holders of ADA, BTC, ETH, SOL, XRP, BNB, AVAX and BAT are eligible to participate in the first phase. Help usher in the next generation of blockchain with rational privacy and cooperative tokenomics on the Midnight network. To learn more, visit https://www.midnight.gd/ and prepare for the Midnight Glacier Drop. - Timestamps: 01:16 Litecoin's Institutional Adoption and Benefits 02:58 Litecoin vs. Bitcoin and Stablecoins 05:19 Institutional Interest in Litecoin 07:25 Future of Crypto Treasury Companies 09:16 Impact of Litecoin on MEI Pharma 11:50 Litecoin's Roadmap and Future Developments - #cryptocurrency #digitalfinance #finance #bitcoin #crypto Subscribe to CoinDesk on YouTube: https://www.youtube.com/user/CoinDesk?sub_confirmation=1 CoinDesk is the leading digital media, events and information services company for the crypto asset and blockchain technology community. Twitter: https://www.twitter.com/coindesk LinkedIn: https://www.din.com/company/coindesk Instagram: https://www.instagram.com/coindesk Facebook: https://www.facebook.com/CoinDesk Newsletters: https://www.coindesk.com/newsletters CoinDesk Podcast Network: https://open.spotify.com/show/2jyIhkvAQhed8AWDZiPpSP Markets Daily Crypto Roundup: https://open.spotify.com/show/7sDXM8BlxsUqzL2IqmLqwE